» Articles » PMID: 22372562

Comprehensive Review of the Clinical Application of Autologous Mesenchymal Stem Cells in the Treatment of Chronic Wounds and Diabetic Bone Healing

Overview
Journal Int Wound J
Date 2012 Mar 1
PMID 22372562
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic ulcerations are a physical and financial burden to the health and economic establishment in the United States and Worldwide. Improvements in biotechnology and knowledge in stem cell applications have progressed and basic science results are making their way slowly into the clinical arena. Chronic wounds and diabetic bone healing are the key components in the limb salvage of the common diabetic foot. We have examined the current available literature and present the latest on stem cells applications as a novel clinical technique in the treatment of chronic wound and diabetic bone healing and their impact in the treatment paradigm of patients.

Citing Articles

Histology Scoring System for Murine Cutaneous Wounds.

van de Vyver M, Boodhoo K, Frazier T, Hamel K, Kopcewicz M, Levi B Stem Cells Dev. 2021; 30(23):1141-1152.

PMID: 34130483 PMC: 9022171. DOI: 10.1089/scd.2021.0124.


Role of stem cell therapies in treating chronic wounds: A systematic review.

Raghuram A, Yu R, Lo A, Sung C, Bircan M, Thompson H World J Stem Cells. 2020; 12(7):659-675.

PMID: 32843920 PMC: 7415243. DOI: 10.4252/wjsc.v12.i7.659.


Mesenchymal stem cell dysfunction in diabetes.

Fijany A, Sayadi L, Khoshab N, Banyard D, Shaterian A, Alexander M Mol Biol Rep. 2018; 46(1):1459-1475.

PMID: 30484107 DOI: 10.1007/s11033-018-4516-x.


Stem Cells and Tissue Engineering: Regeneration of the Skin and Its Contents.

Strong A, Neumeister M, Levi B Clin Plast Surg. 2017; 44(3):635-650.

PMID: 28576253 PMC: 5513194. DOI: 10.1016/j.cps.2017.02.020.


Glucose toxic effects on granulation tissue productive cells: the diabetics' impaired healing.

Berlanga-Acosta J, Schultz G, Lopez-Mola E, Guillen-Nieto G, Garcia-Siverio M, Herrera-Martinez L Biomed Res Int. 2013; 2013:256043.

PMID: 23484099 PMC: 3591209. DOI: 10.1155/2013/256043.


References
1.
Yamaguchi Y, Kubo T, Murakami T, Takahashi M, Hakamata Y, Kobayashi E . Bone marrow cells differentiate into wound myofibroblasts and accelerate the healing of wounds with exposed bones when combined with an occlusive dressing. Br J Dermatol. 2005; 152(4):616-22. DOI: 10.1111/j.1365-2133.2005.06402.x. View

2.
Bruder S, Jaiswal N, Ricalton N, Mosca J, Kraus K, Kadiyala S . Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res. 1999; (355 Suppl):S247-56. DOI: 10.1097/00003086-199810001-00025. View

3.
Dash N, Dash S, Routray P, Mohapatra S, Mohapatra P . Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009; 12(5):359-66. DOI: 10.1089/rej.2009.0872. View

4.
Livingston T, Gordon S, Archambault M, Kadiyala S, McIntosh K, Smith A . Mesenchymal stem cells combined with biphasic calcium phosphate ceramics promote bone regeneration. J Mater Sci Mater Med. 2004; 14(3):211-8. DOI: 10.1023/a:1022824505404. View

5.
Vojtassak J, Danisovic L, Kubes M, Bakos D, Jarabek L, Ulicna M . Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett. 2006; 27 Suppl 2:134-7. View